PRevention of Macular EDema After Cataract Surgery

Trial Profile

PRevention of Macular EDema After Cataract Surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Bromfenac (Primary) ; Dexamethasone (Primary) ; Triamcinolone (Primary)
  • Indications Diabetic macular oedema; Retinal oedema
  • Focus Therapeutic Use
  • Acronyms PREMED
  • Most Recent Events

    • 13 Apr 2017 Status changed from recruiting to completed.
    • 06 Apr 2017 The trial has been completed in Germany, according to European Clinical Trials Database (End date: 13 Jan 2017).
    • 12 Jan 2017 This trial has been completed in Netherlands, according to European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top